Pharmacists and Pharmacy Techs: New CE Requirements. Click here for more info.


Diabetes, Hypertension, and Declining Renal Function

Program Description

Approximately 20 million Americans - 1 in 9 U.S. adults - have chronic kidney disease (CKD) and another 20 million more are at increased risk for developing CKD. Early detection and treatment can help prevent the progression of kidney disease to kidney failure.

The two main causes of CKD are diabetes and high blood pressure, which are, together, responsible for up to two-thirds of the cases. If uncontrolled or poorly controlled, hypertension and diabetes can lead to renal damage that is dramatic, extensive and progressive.

Learning Objectives

Upon completion of this activity, pharmacists will be able to:

  • Compare and contrast diabetes and obesity in the Pediatric Population
  • Explore the natural history of Diabetes Mellitus Type 2 (NIDDM) and advances in the therapeutic strategies
  • Identify the population at risk for macrovascular disease
  • Outline the underlying pathophysiologic process impacting vascular health
  • Identify which patients should be treated for CKD
  • Discuss the pathogenesis and staging of CKD

Faculty

Farhad Zangeneh, MD, FACP, FACE
Assistant Clinical Professor of Medicine
George Washington University School of Medicine
Washington, D.C
Medical Director
Endocrine, Diabetes and Osteoporosis Clinic
Sterling, VA

CE Accreditation

Pharmacists:
Pharmacy CE credits are provided for this program through collaboration between ProCE and OptumHealth. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Program Number 221-999-08-056-H01-P has been assigned to this home-study program (initial release date 06-23-08). This program is approved for 1.0 contact hours (0.10 CEUs) in states that recognize ACPE providers. The program is provided at no cost to participants. Statements of credit will be issued online upon completion of the program evaluation and the post-test with a score of 70% or higher. No partial credit will be given.

Expiration Date: 06/23/2009

Funding
This program was developed by OptumHealth Care Solutions and ProCE, Inc. and supported by an educational grant from Abbott Laboratories.
To Participate

To participate in this Web-based continuing education activity:
1. Review the program description and objectives.
2. Select and view one of the videos that is compatible with your computer software.
3. Take the online post-test and complete the evaluation by clicking the post-test hyperlink on the final slide of the program (registration will be required).
View this Program
View as Streaming Media
Post Test & Evaluation

Take Post-Test
The material presented here does not reflect the views of Pharmacy Choice, Inc.,ProCE, Inc., RxSchool, or the companies providing educational content. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.